Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP992911priorityCriticalpatent/ECSP992911A/en
Publication of ECSP992911ApublicationCriticalpatent/ECSP992911A/en
Organic Low-Molecular-Weight Compounds And Preparation Thereof
(AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Abstract
Un compuesto de la fórmula (gráfico), donde Z y Q son como se han definido en la memoria descriptiva, composiciones farmacéuticas que los contienen y su uso en medicina.A compound of the formula (graph), where Z and Q are as defined in the specification, pharmaceutical compositions containing them and their use in medicine.
ECSP9929111999-04-091999-04-09
BICYCLE DERIVATIVES OF HYDROXAMIC ACID
ECSP992911A
(en)
HETEROAROMATIC COMPOUNDS REPLACED AS INHIBIDORESS TIROSIN QUINASA, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE IN THE PREPARATION OF MEDICINES
AMIDINE COMPOUNDS, PROCESS FOR THEIR PREPARATION, INTERMEDIARY COMPOUNDS, PHARMACEUTICAL FORMULATIONS THAT UNDERSTAND THEM, AND THEIR USE IN THE MANUFACTURE OF A MEDICINAL PRODUCT AS AN INHIBITOR OF NITRIC OXIDE, INDUCIBLE SYNTHESES.
COMPOUNDS DERIVED FROM PIRROL AND IMIDDAZOL; PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM; PREPARATION PROCEDURE; AND ITS USE IN THE TREATMENT AND / OR PREVENTION OF DISEASES THAT ARE ASSOCIATED WITH THE MODULATION OF CANABINOID RECEPTORS
Spontaneously dispersible pharmaceutical composition for oral administration comprising n-benzoyl-staurosporine; method to increase levels of bioavailability. (divisional of only 333-00).